CH657919A5 - Reagens zur beseitigung einer truebung in einer biologischen fluessigkeit. - Google Patents

Reagens zur beseitigung einer truebung in einer biologischen fluessigkeit. Download PDF

Info

Publication number: CH657919A5
Authority: CH; Switzerland
Prior art keywords: active agent; reagent; reagent according; cholesterol; concentration
Prior art date: 1980-10-01

Application number

CH6335/81A

Other languages

German (de)

English (en)

Inventor

Shyun-Long Yun

Luis P Leon

Syed I Ahmad

Original Assignee

Technicon Instr

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1980-10-01

Filing date

1981-10-01

Publication date

1986-09-30

1981-10-01 Application filed by Technicon Instr filed Critical Technicon Instr

1986-09-30 Publication of CH657919A5 publication Critical patent/CH657919A5/de

Links

239000003153 chemical reaction reagent Substances 0.000 title claims description 41
239000007788 liquid Substances 0.000 title description 2
239000004094 surface-active agent Substances 0.000 claims description 39
102000004190 Enzymes Human genes 0.000 claims description 25
108090000790 Enzymes Proteins 0.000 claims description 25
239000000203 mixture Substances 0.000 claims description 22
108010055297 Sterol Esterase Proteins 0.000 claims description 18
102000000019 Sterol Esterase Human genes 0.000 claims description 18
239000000523 sample Substances 0.000 claims description 15
AOMUHOFOVNGZAN-UHFFFAOYSA-N N,N-bis(2-hydroxyethyl)dodecanamide Chemical group CCCCCCCCCCCC(=O)N(CCO)CCO AOMUHOFOVNGZAN-UHFFFAOYSA-N 0.000 claims description 14
239000012472 biological sample Substances 0.000 claims description 14
229940031957 lauric acid diethanolamide Drugs 0.000 claims description 14
108090001060 Lipase Proteins 0.000 claims description 12
102000004882 Lipase Human genes 0.000 claims description 12
239000004367 Lipase Substances 0.000 claims description 12
235000019421 lipase Nutrition 0.000 claims description 12
239000000872 buffer Substances 0.000 claims description 11
125000004432 carbon atom Chemical group C* 0.000 claims description 11
125000000217 alkyl group Chemical group 0.000 claims description 8
125000003342 alkenyl group Chemical group 0.000 claims description 6
VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical group OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 claims description 6
VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 claims description 6
LPMBTLLQQJBUOO-KTKRTIGZSA-N (z)-n,n-bis(2-hydroxyethyl)octadec-9-enamide Chemical group CCCCCCCC\C=C/CCCCCCCC(=O)N(CCO)CCO LPMBTLLQQJBUOO-KTKRTIGZSA-N 0.000 claims description 4
-1 capric acid di-ethanolamine Chemical compound 0.000 claims description 4
244000060011 Cocos nucifera Species 0.000 claims description 3
235000013162 Cocos nucifera Nutrition 0.000 claims description 3
239000002253 acid Substances 0.000 claims description 3
SKDZEPBJPGSFHS-UHFFFAOYSA-N n,n-bis(2-hydroxyethyl)tetradecanamide Chemical compound CCCCCCCCCCCCCC(=O)N(CCO)CCO SKDZEPBJPGSFHS-UHFFFAOYSA-N 0.000 claims description 3
BTBUEUYNUDRHOZ-UHFFFAOYSA-N Borate Chemical compound [O-]B([O-])[O-] BTBUEUYNUDRHOZ-UHFFFAOYSA-N 0.000 claims description 2
KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 claims description 2
239000007983 Tris buffer Substances 0.000 claims description 2
238000005375 photometry Methods 0.000 claims description 2
LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 claims description 2
239000004698 Polyethylene Substances 0.000 claims 1
229920000573 polyethylene Polymers 0.000 claims 1
KDYFGRWQOYBRFD-UHFFFAOYSA-L succinate(2-) Chemical compound [O-]C(=O)CCC([O-])=O KDYFGRWQOYBRFD-UHFFFAOYSA-L 0.000 claims 1
HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 48
235000012000 cholesterol Nutrition 0.000 description 24
210000002966 serum Anatomy 0.000 description 15
239000003795 chemical substances by application Substances 0.000 description 9
238000005352 clarification Methods 0.000 description 8
POULHZVOKOAJMA-UHFFFAOYSA-N dodecanoic acid Polymers CCCCCCCCCCCC(O)=O POULHZVOKOAJMA-UHFFFAOYSA-N 0.000 description 7
230000001000 lipidemic effect Effects 0.000 description 7
NRHMKIHPTBHXPF-TUJRSCDTSA-M sodium cholate Chemical compound [Na+].C([C@H]1C[C@H]2O)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC([O-])=O)C)[C@@]2(C)[C@@H](O)C1 NRHMKIHPTBHXPF-TUJRSCDTSA-M 0.000 description 7
DRBBFCLWYRJSJZ-UHFFFAOYSA-N N-phosphocreatine Chemical compound OC(=O)CN(C)C(=N)NP(O)(O)=O DRBBFCLWYRJSJZ-UHFFFAOYSA-N 0.000 description 6
150000003626 triacylglycerols Chemical class 0.000 description 6
241001465754 Metazoa Species 0.000 description 5
238000004458 analytical method Methods 0.000 description 5
150000001840 cholesterol esters Chemical class 0.000 description 5
238000009472 formulation Methods 0.000 description 5
238000000034 method Methods 0.000 description 5
244000005700 microbiome Species 0.000 description 5
RLFWWDJHLFCNIJ-UHFFFAOYSA-N 4-aminoantipyrine Chemical compound CN1C(C)=C(N)C(=O)N1C1=CC=CC=C1 RLFWWDJHLFCNIJ-UHFFFAOYSA-N 0.000 description 4
230000000694 effects Effects 0.000 description 4
OFGDSGVGRWPQJQ-UHFFFAOYSA-N 1h-imidazol-1-ium;acetate Chemical compound CC(O)=O.C1=CNC=N1 OFGDSGVGRWPQJQ-UHFFFAOYSA-N 0.000 description 3
108010089254 Cholesterol oxidase Proteins 0.000 description 3
KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 3
102000004895 Lipoproteins Human genes 0.000 description 3
108090001030 Lipoproteins Proteins 0.000 description 3
239000007864 aqueous solution Substances 0.000 description 3
238000006243 chemical reaction Methods 0.000 description 3
SHPKCSFVQGSAJU-UAIGNFCESA-L dipotassium;(z)-but-2-enedioate Chemical compound [K+].[K+].[O-]C(=O)\C=C/C([O-])=O SHPKCSFVQGSAJU-UAIGNFCESA-L 0.000 description 3
238000006911 enzymatic reaction Methods 0.000 description 3
210000004923 pancreatic tissue Anatomy 0.000 description 3
210000002381 plasma Anatomy 0.000 description 3
MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 2
208000031226 Hyperlipidaemia Diseases 0.000 description 2
102000003855 L-lactate dehydrogenase Human genes 0.000 description 2
108700023483 L-lactate dehydrogenases Proteins 0.000 description 2
239000005639 Lauric acid Substances 0.000 description 2
102000003992 Peroxidases Human genes 0.000 description 2
108091000080 Phosphotransferase Proteins 0.000 description 2
239000002202 Polyethylene glycol Substances 0.000 description 2
239000013504 Triton X-100 Substances 0.000 description 2
229920004890 Triton X-100 Polymers 0.000 description 2
239000008351 acetate buffer Substances 0.000 description 2
150000001408 amides Chemical class 0.000 description 2
150000001875 compounds Chemical class 0.000 description 2
239000000470 constituent Substances 0.000 description 2
238000011534 incubation Methods 0.000 description 2
239000004615 ingredient Substances 0.000 description 2
230000003993 interaction Effects 0.000 description 2
239000000463 material Substances 0.000 description 2
BPXGKRUSMCVZAF-UHFFFAOYSA-N n,n-bis(2-hydroxyethyl)decanamide Chemical compound CCCCCCCCCC(=O)N(CCO)CCO BPXGKRUSMCVZAF-UHFFFAOYSA-N 0.000 description 2
210000000496 pancreas Anatomy 0.000 description 2
108040007629 peroxidase activity proteins Proteins 0.000 description 2
102000020233 phosphotransferase Human genes 0.000 description 2
229920001223 polyethylene glycol Polymers 0.000 description 2
ZLVSYODPTJZFMK-UHFFFAOYSA-M sodium 4-hydroxybenzoate Chemical compound [Na+].OC1=CC=C(C([O-])=O)C=C1 ZLVSYODPTJZFMK-UHFFFAOYSA-M 0.000 description 2
239000000243 solution Substances 0.000 description 2
UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 2
BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
ORLFVWPPBMVPNZ-UHFFFAOYSA-N 1-(6-methylheptyl)-4-[4-(6-methylheptyl)phenoxy]benzene Chemical compound C1=CC(CCCCCC(C)C)=CC=C1OC1=CC=C(CCCCCC(C)C)C=C1 ORLFVWPPBMVPNZ-UHFFFAOYSA-N 0.000 description 1
PRYIJAGAEJZDBO-ZEQHCUNVSA-N 5,6alpha-epoxy-5alpha-cholestan-3beta-ol Chemical group C([C@]12O[C@H]1C1)[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 PRYIJAGAEJZDBO-ZEQHCUNVSA-N 0.000 description 1
108010029731 6-phosphogluconolactonase Proteins 0.000 description 1
102100031126 6-phosphogluconolactonase Human genes 0.000 description 1
102100036475 Alanine aminotransferase 1 Human genes 0.000 description 1
108010082126 Alanine transaminase Proteins 0.000 description 1
108010003415 Aspartate Aminotransferases Proteins 0.000 description 1
102000004625 Aspartate Aminotransferases Human genes 0.000 description 1
201000001320 Atherosclerosis Diseases 0.000 description 1
241000222120 Candida <Saccharomycetales> Species 0.000 description 1
108010018962 Glucosephosphate Dehydrogenase Proteins 0.000 description 1
102000005548 Hexokinase Human genes 0.000 description 1
108700040460 Hexokinases Proteins 0.000 description 1
108010001336 Horseradish Peroxidase Proteins 0.000 description 1
DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
229910019142 PO4 Inorganic materials 0.000 description 1
ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
OFOBLEOULBTSOW-UHFFFAOYSA-N Propanedioic acid Natural products OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 1
ABBQHOQBGMUPJH-UHFFFAOYSA-M Sodium salicylate Chemical compound [Na+].OC1=CC=CC=C1C([O-])=O ABBQHOQBGMUPJH-UHFFFAOYSA-M 0.000 description 1
241000179532 [Candida] cylindracea Species 0.000 description 1
XJLXINKUBYWONI-DQQFMEOOSA-N [[(2r,3r,4r,5r)-5-(6-aminopurin-9-yl)-3-hydroxy-4-phosphonooxyoxolan-2-yl]methoxy-hydroxyphosphoryl] [(2s,3r,4s,5s)-5-(3-carbamoylpyridin-1-ium-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl phosphate Chemical compound NC(=O)C1=CC=C[N+]([C@@H]2[C@H]([C@@H](O)[C@H](COP([O-])(=O)OP(O)(=O)OC[C@@H]3[C@H]([C@@H](OP(O)(O)=O)[C@@H](O3)N3C4=NC=NC(N)=C4N=C3)O)O2)O)=C1 XJLXINKUBYWONI-DQQFMEOOSA-N 0.000 description 1
230000002159 abnormal effect Effects 0.000 description 1
238000002835 absorbance Methods 0.000 description 1
BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
239000003613 bile acid Substances 0.000 description 1
108010087173 bile salt-stimulated lipase Proteins 0.000 description 1
239000013060 biological fluid Substances 0.000 description 1
239000012496 blank sample Substances 0.000 description 1
239000008395 clarifying agent Substances 0.000 description 1
238000007796 conventional method Methods 0.000 description 1
229960003964 deoxycholic acid Drugs 0.000 description 1
235000014113 dietary fatty acids Nutrition 0.000 description 1
125000003438 dodecyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
150000002148 esters Chemical class 0.000 description 1
RTZKZFJDLAIYFH-UHFFFAOYSA-N ether Substances CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 1
201000005577 familial hyperlipidemia Diseases 0.000 description 1
229930195729 fatty acid Natural products 0.000 description 1
239000000194 fatty acid Substances 0.000 description 1
150000004665 fatty acids Chemical class 0.000 description 1
208000019622 heart disease Diseases 0.000 description 1
230000003301 hydrolyzing effect Effects 0.000 description 1
208000020346 hyperlipoproteinemia Diseases 0.000 description 1
238000007689 inspection Methods 0.000 description 1
230000002452 interceptive effect Effects 0.000 description 1
150000002632 lipids Chemical class 0.000 description 1
239000011976 maleic acid Substances 0.000 description 1
235000011090 malic acid Nutrition 0.000 description 1
239000001630 malic acid Substances 0.000 description 1
PJUIMOJAAPLTRJ-UHFFFAOYSA-N monothioglycerol Chemical compound OCC(O)CS PJUIMOJAAPLTRJ-UHFFFAOYSA-N 0.000 description 1
230000003287 optical effect Effects 0.000 description 1
NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
239000010452 phosphate Substances 0.000 description 1
229910052700 potassium Inorganic materials 0.000 description 1
239000011591 potassium Substances 0.000 description 1
XAEFZNCEHLXOMS-UHFFFAOYSA-M potassium benzoate Chemical compound [K+].[O-]C(=O)C1=CC=CC=C1 XAEFZNCEHLXOMS-UHFFFAOYSA-M 0.000 description 1
238000002360 preparation method Methods 0.000 description 1
235000018102 proteins Nutrition 0.000 description 1
102000004169 proteins and genes Human genes 0.000 description 1
108090000623 proteins and genes Proteins 0.000 description 1
239000011541 reaction mixture Substances 0.000 description 1
150000003839 salts Chemical class 0.000 description 1
229910052708 sodium Inorganic materials 0.000 description 1
239000011734 sodium Substances 0.000 description 1
FHHPUSMSKHSNKW-SMOYURAASA-M sodium deoxycholate Chemical compound [Na+].C([C@H]1CC2)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC([O-])=O)C)[C@@]2(C)[C@@H](O)C1 FHHPUSMSKHSNKW-SMOYURAASA-M 0.000 description 1
159000000000 sodium salts Chemical class 0.000 description 1
239000008137 solubility enhancer Substances 0.000 description 1
230000007928 solubilization Effects 0.000 description 1
238000005063 solubilization Methods 0.000 description 1
239000000126 substance Substances 0.000 description 1
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1

Classifications

- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/34—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
- C12Q1/44—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase involving esterase
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/60—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving cholesterol

Landscapes

Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Organic Chemistry (AREA)
Zoology (AREA)
Molecular Biology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Wood Science & Technology (AREA)
Immunology (AREA)
General Health & Medical Sciences (AREA)
Analytical Chemistry (AREA)
Biotechnology (AREA)
Physics & Mathematics (AREA)
Biochemistry (AREA)
Microbiology (AREA)
Urology & Nephrology (AREA)
Bioinformatics & Cheminformatics (AREA)
General Engineering & Computer Science (AREA)
Biophysics (AREA)
Genetics & Genomics (AREA)
Biomedical Technology (AREA)
Hematology (AREA)
Cell Biology (AREA)
Food Science & Technology (AREA)
Medicinal Chemistry (AREA)
General Physics & Mathematics (AREA)
Pathology (AREA)
Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Investigating Or Analysing Biological Materials (AREA)
Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)

CH6335/81A 1980-10-01 1981-10-01 Reagens zur beseitigung einer truebung in einer biologischen fluessigkeit. CH657919A5 (de)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US19265180A	1980-10-01	1980-10-01

Publications (1)

Publication Number	Publication Date
CH657919A5 true CH657919A5 (de)	1986-09-30

Family

ID=22710512

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
CH6335/81A CH657919A5 (de)	1980-10-01	1981-10-01	Reagens zur beseitigung einer truebung in einer biologischen fluessigkeit.

Country Status (11)

Country	Link
JP (2)	JPS5780560A (sv)
AU (1)	AU543239B2 (sv)
BE (1)	BE890479A (sv)
CA (1)	CA1163908A (sv)
CH (1)	CH657919A5 (sv)
DE (1)	DE3138602A1 (sv)
FR (1)	FR2495184B1 (sv)
GB (1)	GB2084726B (sv)
IT (1)	IT1144750B (sv)
NL (1)	NL8104304A (sv)
SE (1)	SE449005B (sv)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPS60227171A (ja) *	1984-04-25	1985-11-12	Sogo Seibutsu Igaku Kenkyusho:Kk	ヘモグロビンに結合したグルコ−スの測定方法
FR2599149B1 (fr) *	1986-05-21	1988-08-26	Univ Nancy	Reactif pour la transparisation de milieux biologiques et ses applications analytiques.
DE3620817A1 (de) *	1986-06-21	1987-12-23	Boehringer Mannheim Gmbh	Verfahren zur spezifischen bestimmung des serumfructosamingehalts sowie hierfuer geeignetes reagenzgemisch
ES2272037T3 (es)	1998-12-22	2007-04-16	Olympus Life And Material Science Europa Gmbh	Reactivo liquido para la deteccion de creatina cinasa.
EP1599169A4 (en)	2003-02-28	2008-01-23	E L Management Corp	PROCESS FOR REINFORCING HAIR GROWTH
JP2006071574A (ja) *	2004-09-06	2006-03-16	Denka Seiken Co Ltd	免疫比濁法及びそのための試薬

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US2089212A (en) *	1936-06-08	1937-08-10	Kritchevsky Wolf	Hydrotropic fatty material and method of making same
US2531190A (en) *	1946-11-12	1950-11-21	Drew & Co Inc E F	Emulsifier consisting of alkylolamine-fatty acid condensation products and esters ofpolyglycols
US3260648A (en) *	1963-08-16	1966-07-12	Warner Lambert Pharmaceutical	Diagnostic aid
US3853465A (en) *	1972-06-09	1974-12-10	Technicon Instr	Turbidity reduction in serum and plasma samples using polyoxyethylated lauric acid compounds
US3898130A (en) *	1974-03-18	1975-08-05	American Hospital Supply Corp	Rapid enzymatic hydrolysis of triglycerides
DE2724757C2 (de) *	1977-06-01	1979-08-23	Boehringer Mannheim Gmbh, 6800 Mannheim	Mittel zur Beseitigung von Trübungen in Serum und Verfahren zu seiner Herstellung
DE2816229C2 (de) *	1978-04-14	1983-11-10	Boehringer Mannheim Gmbh, 6800 Mannheim	Verfahren und Mittel zur Beseitigung von Trübungen

1981
- 1981-06-23 CA CA000380441A patent/CA1163908A/en not_active Expired
- 1981-07-15 AU AU72876/81A patent/AU543239B2/en not_active Ceased
- 1981-07-30 IT IT68070/81A patent/IT1144750B/it active
- 1981-08-27 JP JP56133441A patent/JPS5780560A/ja active Granted
- 1981-09-18 NL NL8104304A patent/NL8104304A/nl not_active Application Discontinuation
- 1981-09-24 BE BE0/206050A patent/BE890479A/fr not_active IP Right Cessation
- 1981-09-24 GB GB8128928A patent/GB2084726B/en not_active Expired
- 1981-09-28 FR FR8118203A patent/FR2495184B1/fr not_active Expired
- 1981-09-29 DE DE19813138602 patent/DE3138602A1/de active Granted
- 1981-09-29 SE SE8105737A patent/SE449005B/sv not_active IP Right Cessation
- 1981-10-01 CH CH6335/81A patent/CH657919A5/de not_active IP Right Cessation
1989
- 1989-04-18 JP JP1096552A patent/JPH01304898A/ja active Granted

Also Published As

Publication number	Publication date
BE890479A (fr)	1982-03-24
SE8105737L (sv)	1982-04-02
IT1144750B (it)	1986-10-29
JPH0151782B2 (sv)	1989-11-06
FR2495184B1 (fr)	1985-06-28
CA1163908A (en)	1984-03-20
SE449005B (sv)	1987-03-30
AU7287681A (en)	1982-04-08
NL8104304A (nl)	1982-05-03
JPH01304898A (ja)	1989-12-08
JPS5780560A (en)	1982-05-20
GB2084726B (en)	1983-11-23
FR2495184A1 (fr)	1982-06-04
DE3138602A1 (de)	1982-06-24
AU543239B2 (en)	1985-04-04
DE3138602C2 (sv)	1993-02-11
JPH0474000B2 (sv)	1992-11-25
GB2084726A (en)	1982-04-15
IT8168070A0 (it)	1981-07-30

Publication	Publication Date	Title
DE2265122C2 (de)	1982-08-19	Verfahren zur Bestimmung von Cholesterin
DE3249743C2 (sv)	1990-10-04
EP0016947B1 (de)	1983-07-13	Verfahren und Reagenz zur enzymatischen Bestimmung von Enzymsubstraten
DE2000127C3 (de)	1974-12-12	Verfahren zur quantitativen Spaltung und zum quantitativen Nachweis von Tri-, Di- und Monoglyceriden
DE3636851A1 (de)	1988-05-11	Verfahren und reagenz zur spezifischen bestimmung des cholesterins der hdl-fraktion
EP0186134A1 (de)	1986-07-02	Mittel zur Verbesserung des Nachweises Wasserstoffperoxid liefernder Oxidase-Reaktionen und seine Verwendung
EP0250991B1 (de)	1993-01-27	Verfahren zur spezifischen Bestimmung des Serumfructosamingehalts sowie hierfür geeignetes Reagenzgemisch
DE2724758A1 (de)	1977-12-15	Zusammensetzung und verfahren zur hydrolyse von glycerinestern
DE2904305B1 (de)	1980-08-14	Reagens zur Lipasebestimmung und Verfahren zu seiner Herstellung
US4503146A (en)	1985-03-05	Method for eliminating turbidity in a biological fluid and reagent therefor
CH657919A5 (de)	1986-09-30	Reagens zur beseitigung einer truebung in einer biologischen fluessigkeit.
DE1945663B2 (de)	1981-04-02	Diagnostikum zur Bestimmung von Pankreas-Enzymen in Körperflüssigkeiten
DE69026611T2 (de)	1996-08-14	Verfahren zur Bestimmung von Fruktosaminen
DE60318685T2 (de)	2008-12-24	Verfahren zur quantifizierung von cholesterin in hd-(high density)-lipoprotein und reagenszusammensetzungen
DE2523697C2 (de)	1986-09-18	S-Acylverbindungen und deren Verwendung zur Lipasen-Aktivitätsbestimmung
DE69128873T2 (de)	1998-05-28	Verfahren zur enzymatischen Messung von Wasserstoffperoxid und Reagenz dafür
DE2323609A1 (de)	1974-06-27	Verfahren zur quantitativen bestimmung von triglycerid
DE3006789A1 (de)	1980-09-04	Verfahren und enzymzusammensetzung zur hydrolyse von glycerinestern
EP0863995B1 (de)	2003-05-21	Verbessertes verfahren zur bestimmung von lipase
DE69030135T2 (de)	1997-06-19	Ein Reagenssystem zur Bestimmung von Lipase
DE2804356C2 (de)	1995-07-13	Verfahren zur Hydrolyse von proteingebundenen Cholesterinestern
DE69219855T2 (de)	1997-09-11	Verfahren zur Bestimmung der alpha-Amylase-Aktivität
DD201734A5 (de)	1983-08-03	Verfahren und reagens zur bestimmung von glycerin
EP0848066B1 (de)	2003-11-12	Mittel und Verfahren zur Bestimmung von hydrolytischen Enzymen
EP0144798B1 (de)	1990-06-27	Verfahren und Reagenz zur Bestimmung von Glycerin mittels eines kompetitiven Inhibitors für Glycerinkinase

Legal Events

Date	Code	Title	Description
1989-07-14	PUE	Assignment	Owner name: TECHNICON INSTRUMENTS CORPORATION TRANSFER- TECHNI
1994-06-30	PL	Patent ceased
2024-10-31	PL	Patent ceased